KRNMF Stock Chart & Stats
$4.63
$0.04(0.98%)
―
--
Day’s Range― - ―
52-Week Range$3.96 - $5.27
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$1.64B
Enterprise Value$8.46B
Total Cash (Recent Filing)$821.56M
Total Debt (Recent Filing)$7.81B
Price to Earnings (P/E)403.8
Beta0.09
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-8.51
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio2.42
Enterprise Value/Market Cap5.15
Enterprise Value/Revenue1.59
Enterprise Value/Gross Profit11.46
Enterprise Value/Ebitda6.26
Forecast
1Y Price Target
$5.37Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.46
Revenue Forecast (FY)$6.12B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthClariane shows a multi-year upward revenue trend with accelerating top-line growth, driven by utilization across residential, clinic and home-care services. Durable demand for long-term care and steady utilization support sustainable revenue expansion and scale economics over months to years.
Cash Generation / Free Cash FlowConsistently positive operating cash flow and improving free cash flow provide internal financing for capex, facility upkeep and selective growth. Reliable cash conversion reduces reliance on markets for short-term needs and supports operational continuity despite cyclical pressures.
Essential, Diversified Care ModelThe company's diversified care footprint—nursing homes, clinics and home health—creates recurring, sticky revenue tied to essential services. Public reimbursement and demographic ageing create structural demand, reducing revenue cyclicality and supporting long-term occupancy and service utilization.
Bears Say
High And Rising LeverageElevated and increasing leverage materially raises refinancing and interest-rate sensitivity, constraining strategic flexibility. High debt loads limit ability to absorb shocks or fund M&A, and increase default risk if cash generation weakens or funding costs rise over the medium term.
Net Income VolatilityDespite stable operating margins, reported earnings are volatile and near zero, indicating financing and non-operating items erode profitability. Weak bottom-line results undermine reserve building, limit retained earnings for reinvestment, and amplify the impact of cyclical pressures.
Reimbursement & Labor ExposureHeavy dependence on regulated public reimbursement and labour-intensive delivery makes margins sensitive to policy shifts and wage inflation. Across multiple countries, adverse tariff changes or staffing shortages could structurally raise operating costs and compress long-term profitability.
KRNMF FAQ
What was Clariane’s price range in the past 12 months?
Clariane lowest stock price was $3.96 and its highest was $5.27 in the past 12 months.
What is Clariane’s market cap?
Clariane’s market cap is $1.64B.
When is Clariane’s upcoming earnings report date?
Clariane’s upcoming earnings report date is Jul 29, 2026 which is in 13 days.
How were Clariane’s earnings last quarter?
Clariane released its earnings results on Feb 26, 2026. The company reported $0.193 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Clariane overvalued?
According to Wall Street analysts Clariane’s price is currently Undervalued.
Does Clariane pay dividends?
Clariane does not currently pay dividends.
What is Clariane’s EPS estimate?
Clariane’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clariane have?
Currently, no data Available
What happened to Clariane’s price movement after its last earnings report?
Clariane reported an EPS of $0.193 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Clariane?
Currently, no hedge funds are holding shares in KRNMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Clariane
Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
KRNMF Stock 12 Month Forecast
Average Price Target
$5.37
Ownership Overview
―
Insiders
2.95% Mutual Funds
― Other Institutional Investors
93.48% Public Companies and
Individual Investors